Cited by 128Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsNeurological Disease Mechanisms and Treatments

The DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.

Phenotypic profile of alternative activation marker CD163 is different in Alzheimer’s and Parkinson’s disease

Open access

Pey, Peixuan, Pearce, Ronald KB, Kalaitzakis, Michail E, Griffin, W Sue T, Gentleman, Steve M·2014·Acta Neuropathologica Communications

DOI 10.1186/2051-5960-2-21PMC PMC3940003

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Microglial activation is a pathological feature common to both Alzheimer's and Parkinson's diseases (AD and PD). The classical activation involves release of pro-inflammatory cytokines and reactive oxygen species. This is necessary for maintenance of tissue homeostasis and host defense, but can cause bystander damage when the activation is sustained and uncontrolled. In recent years the heterogeneous nature of microglial activation states in neurodegenerative diseases has become clear and the focus has shifted to alternative activation states that promote tissue maintenance and repair. We studied the distribution of CD163, a membrane-bound scavenger receptor found on perivascular macrophages. CD163 has an immunoregulatory function, and has been found in the parenchyma in other inflammatory diseases e.g. HIV-encephalitis and multiple sclerosis. In this study, we used immunohistochemistry to compare CD163 immunoreactivity in 31 AD cases, 27 PD cases, and 16 control cases. Associations of microglia with pathological hallmarks of AD and PD were investigated using double immunofluorescence. RESULTS: Parenchymal microglia were found to be immunoreactive for CD163 in all of the AD cases, and to a lesser extent in PD cases. There was prominent staining of CD163 immunoreactive microglia in the frontal and occipital cortices of AD cases, and in the brainstem of PD cases. Many of them were associated with Aß plaques in both diseases, and double staining with CD68 demonstrates their phagocytic capability. Leakage of fibrinogen was observed around compromised blood vessels, raising the possibility these microglia might have originated from the periphery. CONCLUSIONS: Increase in microglia's CD163 immunoreactivity was more significant in AD than PD, and association of CD163 immunoreactive microglia with Aβ plaques indicate microglia's attraction towards extracellular protein pathology, i.e. extracellular aggregates of Aβ as compared to intracellular Lewy Bodies in PD. Double staining with CD163 and CD68 might point towards their natural inclination to phagocytose plaques. Fibrinogen leakage and compromise of the blood brain barrier raise the possibility that these are not resident microglia, but systemic macrophages infiltrating the brain.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/2051-5960-2-21

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Figure 1 Schematic representation of the structure and domain organization of membrane-bound CD163. CD163 consists of a 1003 amino acid extracellular portion with 9 class B scavenger receptor cysteine-rich (SRCR) domains, with domains 6 and 7 separated by a 31 amino acid linker. This linker is composed of many proline, serine and threonine residues (PST). Another PST linker connects the last SRCR domain to the transmembrane segment, which is made up of 24 amino acids. The intracellular cytoplasmic domain ranges from 49 to 89 amino acids that contain consensus sequences for phosphorylation and internalization.CC BY · PubMed Central

Figure 2 Immunohistochemical detection of CD163. (a-c) a- PVM immunoreactive for CD163 in the frontal cortex of a control case. b- Parenchymal microglia immunoreactive for CD163 in the occipital cortex of an AD case. c- CD163 immunoreactive microglia in close proximity to meningeal spaces in the occipital lobe of an AD case. (d-f) Range of CD163 immunoreactivity (based on %area) in microglia from d-mild, e-moderate, to f-severe.CC BY · PubMed Central

Figure 3 Comparison of percentage area of CD163 immunoreactive microglia in various brain regions of AD and PD cases. %area of CD163 immunoreactive microglia was assessed in all available brain regions in 31 AD cases and 27 PD cases. Significant differences were observed from comparison of the median between the frontal lobe and hippocampal regions (CA1, CA3, CA4, subiculum and entorhinal cortex) of AD and PD cases. Columns represent mean %area of CD163 immunoreactive microglia in their respective brain regions for AD and PD cases.CC BY · PubMed Central

Figure 4 Double immunofluorescence of CD163 with microglia/macrophage markers Iba1 and MRC1. (a and b) Double immunofluorescence for CD163 (red) and Iba1 (green) in the occipital cortex of AD cases. Not all CD163 immunoreactive microglia stained for Iba1 (arrows), a marker highly specific for microglia. This suggests that CD163 immunoreactive parenchyma microglia might originate from systemic cells that have yet to obtain an Iba1 immunoreactive profile. The presence of microglia immunoreactive for both Iba1 and CD163 also indicate that resident microglia might be able to upregulate CD163 with stimulation from the periphery. (c) Double immunofluorescence for CD163 (red) and MRC1 (green) in the occipital cortex of an AD case. CD163 co-stains PVM with MRC1. MRC1 immunoreactivity is limited to PVM (circled). This is in concordance with findings that MRC1 is restricted to PVM despite a clear BBB breakdown.CC BY · PubMed Central

Figure 5 Double immunofluorescence of CD163 with fibrinogen. (a and b) Immunofluorescence for fibrinogen in the (a) occipital cortex of an AD case and (b) cingulate cortex of a PD case. Fibrinogen was found to exude from compromised blood vessels in both AD and PD cases, but to a lesser extent in the PD cases. Arrows point to compromised blood vessels where fibrinogen has leaked into the surrounding parenchyma. (c and d) Double immunofluorescence for CD163 (red) and fibrinogen (green) in the (c) frontal and (d) occipital cortex of AD cases. Presence of CD163 immunoreactive microglia at close proximity to areas of fibrinogen leakage in the parenchyma. This raises the possibility that CD163 immunoreactive microglia are a result of migration from the periphery. Astrocytes were also found to have fibrinogen immunoreactivity.CC BY · PubMed Central

Figure 6 Double immunofluorescence detection of CD163 with Aβ, α-syn and CD68. (a) Double immunofluorescence for CD163 (red) and Aβ (green) in the occipital cortex of an AD case. CD163 immunoreactive microglia clusters around dense cored plaques. (b) Double immunofluorescence for CD163 (red) and α-syn (green) in the frontal cortex of a PD case. CD163 immunoreactive microglia cluster around extracellular LBs. Most of the LBs were intracellular and did not coincide with CD163 immunoreactive microglia. It is predictable that these microglia would react with abnormal aggregates of protein found extracellularly, instead of intracellular pathology. (c) Double immunofluorescence for CD163 (red) and tau (green) in the hippocampus of an AD case. CD163 immunoreactive microglia are in close proximity with neuropil thread but with no specific associations. (d) Double immunofluorescence for CD163 (red) and CD68 (green) in the frontal cortex of an AD case. CD68 is a marker for lysosomes; association (arrow) indicates possible phagocytic properties of CD163 immunoreactive microglia, reinforcing its role as a scavenger receptor.CC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Physiology of Microglia
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
Holmes, C., Boche, D., Wilkinson, D., Yadegarfar, G., Hopkins, V., Bayer, A., Jones, R. W., Bullock, R., Love, S., Neal, J. W., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61075-2 · Cited by 1,416 · cited 1×
“Much interest has been shown in Aβ and its removal from the brain via natural methods or vaccination [58]; CD163 immunoreactive microglia clusters around Aβ plaques support the idea that they might serve a similar purpose.”
Background
Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329 · cited 2×
“via downregulation of Aβ receptors [22] and neuronal degeneration, but TNF-α is protective due to its pre-conditioning effect on metabolic excitotoxicity, Aβ toxicity and ischaemia [23].”
Background
Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's Disease
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
Tansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045
Macrophage activation switching: an asset for the resolution of inflammation
Porcheray, F., Viaud, S., Rimaniol, A.-C., Léone, C., Samah, B., Dereuddre-Bosquet, N., Dormont, D., & Gras, G. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02934.x · Cited by 840
Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli
Buechler, C., Ritter, M., Orsó, E., Langmann, T., Klucken, J., & Schmitz, G. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.1.97 · Cited by 704

Show all 71 references

Sorted by citations

Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616
hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data
Morabito, S., Reese, F., Rahimzadeh, N., Miyoshi, E., & Swarup, V. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100498 · Cited by 773
Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review
Hopperton, K. E., Mohammad, D., Trépanier, M. O., Giuliano, V, & Bazinet, R. P. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.246 · Cited by 567
Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains
Walker, D. G., & Lue, L.-F. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0139-9 · Cited by 562
Targeting iron metabolism in drug discovery and delivery
Crielaard, B. J., Lammers, T., & Rivella, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.248 · Cited by 352
Periphery and brain, innate and adaptive immunity in Parkinson’s disease
Harms, A. S., Ferreira, S. A., & Romero‐Ramos, M. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02268-5 · Cited by 291
CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease
Galiano-Landeira, J., Torra, A., Vila, M., & Bové, J. (2020) · Brain · doi:10.1093/brain/awaa269 · Cited by 267
Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases
Skytthe, M. K., Graversen, J. H., & Moestrup, S. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155497 · Cited by 275
APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer’s disease
Nguyen, A. T., Wang, K., Hu, G., Wang, X., Miao, Z., Azevedo, J. A., Suh, E., Van Deerlin, V. M., Choi, D., Roeder, K., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02200-3 · Cited by 241
Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma
Lisi, L., Ciotti, G. M. P., Braun, D. J., Kalinin, S., Currò, D., Russo, C. D., Coli, A., Mangiola, A., Anile, C., Feinstein, D. L., et al. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.02.076 · Cited by 228
Immune system responses in Parkinson's disease: Early and dynamic
Tansey, M. G., & Romero‐Ramos, M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14290 · Cited by 193
α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration
Harms, A. S., Delic, V., Thome, A. D., Bryant, N., Liu, Z., Chandra, S., Jurkuvenaite, A., & West, A. B. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0494-9 · Cited by 181
Therapeutic effects of glatiramer acetate and grafted CD115+monocytes in a mouse model of Alzheimer’s disease
Koronyo, Y., Salumbides, B. C., Sheyn, J., Pelissier, L., Li, S., Ljubimov, V., Moyseyev, M., Daley, D., Fuchs, D.-T., Pham, M., et al. (2015) · Brain · doi:10.1093/brain/awv150 · Cited by 153
The immune system in Parkinson's disease: what we know so far
Roodveldt, C., Bernardino, L. I., Çakmak, Ö. Ö., Dragić, M., Fladmark, K. E., Ertan, S., Aktaş, B., Pita, C., Ciglar, L., Garraux, G., et al. (2024) · Brain · doi:10.1093/brain/awae177 · Cited by 151
Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer’s Disease Brains
Walker, D. G., Tang, T. M., Mendsaikhan, A., Tooyama, I., Serrano, G. E., Sue, L. I., Beach, T. G., & Lue, L.-F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020678 · Cited by 128
Role of Macrophages in Brain Tumor Growth and Progression
Guadagno, E., Presta, I., Maisano, D., Donato, A., Pirrone, C., Cardillo, G., Corrado, S., Mignogna, C., Mancuso, T., Donato, G., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041005 · Cited by 118
Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia
Purves-Tyson, T. D., Robinson, K., Brown, A. M., Boerrigter, D., Cai, H. Q., Weissleder, C., Owens, S. J., Rothmond, D. A., & Weickert, C. S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02002 · Cited by 114
A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene
Magusali, N., Graham, A. C., Piers, T. M., Panichnantakul, P., Yaman, U., Shoai, M., Reynolds, R. H., Botia, J. A., Brookes, K. J., Guetta-Baranes, T., et al. (2021) · Brain · doi:10.1093/brain/awab337 · Cited by 111
Anti-Inflammatory Modulation of Microglia via CD163-Targeted Glucocorticoids Protects Dopaminergic Neurons in the 6-OHDA Parkinson's Disease Model
Tentillier, N., Etzerodt, A., Olesen, M. N., Rizalar, F. S., Jacobsen, J., Bender, D., Moestrup, S. K., & Romero-Ramos, M. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1636-16.2016 · Cited by 109
Defining molecular identity and fates of CNS-border associated macrophages after ischemic stroke in rodents and humans
Rajan, W. D., Wojtaś, B., Gielniewski, B., Miró‐Mur, F., Pedragosa, J., Zawadzka, M., Pilanc, P., Planas, A. M., & Kaminska, B. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104722 · Cited by 106
Immune responses in the Parkinson's disease brain
Weiss, F. C., Labrador‐Garrido, A., Dzamko, N. L., & Halliday, G. M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105700 · Cited by 100
Molecular changes in the postmortem parkinsonian brain
Toulorge, D., Schapira, A. H. V., & Hajj, R. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13696 · Cited by 95
Alterations in Blood Monocyte Functions in Parkinson's Disease
Nissen, S. K., Shrivastava, K., Schulte, C., Otzen, D. E., Goldeck, D., Berg, D., Møller, H. J., Maetzler, W., & Romero‐Ramos, M. (2019) · Movement Disorders · doi:10.1002/mds.27815 · Cited by 89
Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson’s disease
Kip, E., & Parr‐Brownlie, L. C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101618 · Cited by 89
Identification of a dysfunctional microglial population in human Alzheimer’s disease cortex using novel single-cell histology image analysis
Swanson, M. E. V., Scotter, E. L., Smyth, L. C. D., Murray, H. C., Ryan, B., Turner, C. P., Faull, R. L. M., Dragunow, M., & Curtis, M. A. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01047-9 · Cited by 89
Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy
Kempthorne, L., Yoon, H., Madore, C., Smith, S., Wszolek, Z. K., Rademakers, R., Kim, J., Butovsky, O., & Dickson, D. W. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00947-0 · Cited by 77
“CD163 is a hemoglobin-haptoglobulin scavenger receptor that is considered to be expressed exclusively on perivascular macrophages in the brain under normal conditions, as well as peripheral cells of monocyte lineage [38, 56].”
Background
Vessel-Associated Immune Cells in Cerebrovascular Diseases: From Perivascular Macrophages to Vessel-Associated Microglia
Koizumi, T., Kerkhofs, D., Mizuno, T., Steinbusch, H. W. M., & Foulquier, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01291 · Cited by 74
Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Carter, C. (2017) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-170017 · Cited by 74
Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease
Koronyo‐Hamaoui, M., Sheyn, J., Hayden, E. Y., Li, S., Fuchs, D.-T. S., Regis, G. C., Lopes, D. H. J., Black, K. L., Bernstein, K. E., Teplow, D. B., et al. (2019) · Brain · doi:10.1093/brain/awz364 · Cited by 75
Monocyte-derived cells invade brain parenchyma and amyloid plaques in human Alzheimer’s disease hippocampus
Muñoz-Castro, C., Mejias-Ortega, M., Sanchez-Mejias, E., Navarro, V., Trujillo-Estrada, L., Jimenez, S., Garcia-Leon, J. A., Fernandez-Valenzuela, J. J., Sanchez-Mico, M. V., Romero-Molina, C., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01530-z · Cited by 66
Quantitative immunohistochemical analysis of myeloid cell marker expression in human cortex captures microglia heterogeneity with anatomical context
Swanson, M. E. V., Murray, H. C., Ryan, B., Faull, R. L. M., Dragunow, M., & Curtis, M. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-68086-z · Cited by 65
Distinct non-inflammatory signature of microglia in post-mortem brain tissue of patients with major depressive disorder
Snijders, G. J. L., Sneeboer, M. A. M., Fernández-Andreu, A., Udine, E., (NBB-Psy), P. D. P. O. T. N. B. B., Boks, M. P., Ormel, P. R., van Berlekom, A. B., van Mierlo, H. C., Böttcher, C., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00896-z · Cited by 66
Neuroprotective Activity of Sitagliptin via Reduction of Neuroinflammation beyond the Incretin Effect: Focus on Alzheimer’s Disease
Wiciński, M., Wódkiewicz, E., Słupski, M., Walczak, M., Socha, M. W., Malinowski, B., & Pawlak-Osińska, K. (2018) · BioMed Research International · doi:10.1155/2018/6091014 · Cited by 64
Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson’s disease and cognition
Nissen, S. K., Farmen, K., Carstensen, M., Schulte, C., Goldeck, D., Brockmann, K., & Romero‐Ramos, M. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.01.005 · Cited by 62
Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease
Nissen, S. K., Ferreira, S. A., Nielsen, M. C., Schulte, C., Shrivastava, K., Hennig, D., Etzerodt, A., Graversen, J. H., Berg, D., Maetzler, W., et al. (2020) · Movement Disorders · doi:10.1002/mds.28424 · Cited by 61
TREM1 disrupts myeloid bioenergetics and cognitive function in aging and Alzheimer disease mouse models
Wilson, E. N., Wang, C., Swarovski, M. S., Zera, K. A., Ennerfelt, H. E., Wang, Q., Chaney, A. M., Gauba, E., Benitez, J. A. R., Guen, Y. L., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01610-w · Cited by 60
Adult onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) and N asu– H akola disease: lesion staging and dynamic changes of axons and microglial subsets
Oyanagi, K., Kinoshita, M., Suzuki‐Kouyama, E., Inoue, T., Nakahara, A., Tokiwai, M., Arai, N., Satoh, J., Aoki, N., Jinnai, K., et al. (2016) · Brain Pathology · doi:10.1111/bpa.12443 · Cited by 55
Dwellers and Trespassers: Mononuclear Phagocytes at the Borders of the Central Nervous System
Ivan, D. C., Walthert, S., Berve, K., Steudler, J., & Locatelli, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.609921 · Cited by 55
Links between Immune Cells from the Periphery and the Brain in the Pathogenesis of Epilepsy: A Narrative Review
Yamanaka, G., Morıchı, S., Takamatsu, T., Watanabe, Y., Suzuki, S., Ishida, Y., Oana, S., Yamazaki, T., Takata, F., & Kawashima, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094395 · Cited by 54
Chronic kidney disease leads to microglial potassium efflux and inflammasome activation in the brain
Zimmermann, S., Mathew, A., Bondareva, O., Elwakiel, A., Waldmann, K., Jiang, S., Rana, R., Singh, K. K., Kohli, S., Shahzad, K., et al. (2024) · Kidney International · doi:10.1016/j.kint.2024.06.028 · Cited by 48
Alzheimer’s genes in microglia: a risk worth investigating
Sudwarts, A., & Thinakaran, G. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00679-4 · Cited by 52
Neuroinflammation in Alzheimer’s Disease: Microglia, Molecular Participants and Therapeutic Choices
Wang, H., Shen, Y., Chuang, H.-Y., Chiu, C., Ye, Y., & Zhao, L. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190503151648 · Cited by 43
Single-cell transcriptomic and functional studies identify glial state changes and a role for inflammatory RIPK1 signaling in ALS pathogenesis
Zelic, M., Blazier, A. S., Pontarelli, F., LaMorte, M. J., Huang, J., Tasdemir-Yilmaz, O. E., Ren, Y., Ryan, S. K., Shapiro, C., Morel, C., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.02.024 · Cited by 44
Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development
Kazantseva, M., Eiholzer, R. A., Mehta, S. Y., Taha, A. J., Bowie, S., Roth, I. M., Zhou, J., Joruiz, S. M., Royds, J. A., Hung, N. A., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5111 · Cited by 41
Identification of KIAA0513 and Other Hub Genes Associated With Alzheimer Disease Using Weighted Gene Coexpression Network Analysis
Zhu, M., Jia, L., Li, F., & Jia, J. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00981 · Cited by 40
Time dependent analysis of rat microglial surface markers in traumatic brain injury reveals dynamics of distinct cell subpopulations
Gottlieb, A., Furman, N. E. T., Prabhakara, K. S., Kumar, A., Caplan, H. W., Bedi, S. S., Cox, C. S., & Olson, S. D. (2022) · Scientific Reports · doi:10.1038/s41598-022-10419-1 · Cited by 36
A reappraisal of macrophage polarization in glioblastoma: Histopathological and immunohistochemical findings and review of the literature
Mignogna, C., Signorelli, F., Vismara, M. F. M., Zeppa, P., Camastra, C., Barni, T., Donato, G., & Vito, A. D. (2016) · Pathology - Research and Practice · doi:10.1016/j.prp.2016.02.020 · Cited by 35
Neuropathology of SUDEP
Michalak, Z., Obari, D., Ellis, M. J., Thom, M., & Sisodiya, S. M. (2017) · Neurology · doi:10.1212/wnl.0000000000003584 · Cited by 35
Inhibition of inflammatory cells delays retinal degeneration in experimental retinal vein occlusion in mice
Jovanovic, J., Liu, X., Kokona, D., Zinkernagel, M. S., & Ebneter, A. (2019) · Glia · doi:10.1002/glia.23739 · Cited by 35
Proteomic analysis of human hippocampal subfields provides new insights into the pathogenesis of Alzheimer’s disease and the role of glial cells
Gao, Y., Liu, J., Wang, J., Liu, Y., Zeng, L., Ge, W., & Ma, C. (2022) · Brain Pathology · doi:10.1111/bpa.13047 · Cited by 35
Perivascular macrophages in the CNS : From health to neurovascular diseases
Li, Z., Guo, Y., Zhai, X., Zhang, Y., Chen, W., Zhu, Z., Xuan, W., & Li, P. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13954 · Cited by 36
High-resolution and differential analysis of rat microglial markers in traumatic brain injury: conventional flow cytometric and bioinformatics analysis
Furman, N. E. T., Gottlieb, A., Prabhakara, K. S., Bedi, S. S., Caplan, H. W., Ruppert, K. A., Srivastava, A. K., Olson, S. D., & Cox, C. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-68770-0 · Cited by 32
Varied Composition and Underlying Mechanisms of Gut Microbiome in Neuroinflammation
Farooq, R. K., Alamoudi, W., Alhibshi, A., Rehman, S., Sharma, A. R., & Abdulla, F. A. (2022) · Microorganisms · doi:10.3390/microorganisms10040705 · Cited by 31
Communication of CD 8+ T cells with mononuclear phagocytes in multiple sclerosis
Sabolek, M. K., Held, K., Beltrán, E., Niedl, A. G., Meinl, E., Hohlfeld, R., Lassmann, H., & Dornmair, K. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.783 · Cited by 30
EVOO Polyphenols Exert Anti-Inflammatory Effects on the Microglia Cell through TREM2 Signaling Pathway
Leri, M., Vasarri, M., Carnemolla, F., Oriente, F., Cabaro, S., Stio, M., Degl’Innocenti, D., Stefani, M., & Bucciantini, M. (2023) · Pharmaceuticals · doi:10.3390/ph16070933 · Cited by 29
Drug Trafficking into Macrophages via the Endocytotic Receptor CD163
Graversen, J. H., & Moestrup, S. K. (2015) · Membranes · doi:10.3390/membranes5020228 · Cited by 26
Has the Time Come to Stratify and Score SUDEP Risk to Inform People With Epilepsy of Their Changes in Safety?
Shankar, R., Newman, C. G. J., Gales, A., McLean, B., Hanna, J., Ashby, S., Walker, M. C., & Sander, J. W. A. S. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00281 · Cited by 25
Increased prefrontal cortical cells positive for macrophage/microglial marker CD163 along blood vessels characterizes a neuropathology of neuroinflammatory schizophrenia
Zhu, Y., Webster, M. J., Walker, A. K., Massa, P. T., Middleton, F. A., & Weickert, C. S. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.03.018 · Cited by 25
Distinct neuroinflammatory signatures exist across genetic and sporadic amyotrophic lateral sclerosis cohorts
Rifai, O. M., O’Shaughnessy, J., Dando, O., Munro, A. F., Sewell, M. D. E., Abrahams, S., Waldron, F. M., Sibley, C. R., & Gregory, J. M. (2023) · Brain · doi:10.1093/brain/awad243 · Cited by 23
The role of CNS macrophages in streptococcal meningoencephalitis
Gres, V., Kolter, J., Erny, D., & Henneke, P. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.4mr1118-419r · Cited by 23
The APOE–Microglia Axis in Alzheimer’s Disease: Functional Divergence and Therapeutic Perspectives—A Narrative Review
Liu, A., Wang, T., Yang, L., & Zhou, Y. (2025) · Brain Sciences · doi:10.3390/brainsci15070675 · Cited by 22
Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer’s Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks
Wruck, W., Schröter, F., & Adjaye, J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150733 · Cited by 23
Splitting the “Unsplittable”: Dissecting Resident and Infiltrating Macrophages in Experimental Autoimmune Encephalomyelitis
Koeniger, T., & Küerten, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102072 · Cited by 22
OMIP‐041: Optimized multicolor immunofluorescence panel rat microglial staining protocol
Furman, N. E. T., Prabhakara, K. S., Bedi, S. S., Cox, C. S., & Olson, S. D. (2017) · Cytometry Part A · doi:10.1002/cyto.a.23267 · Cited by 20
Microglia aggregates define distinct immune and neurodegenerative niches in Alzheimer's disease hippocampus
Fixemer, S., de la Maza, M. M., Hammer, G. P., Jeannelle, F., Schreiner, S., Gérardy, J., Boluda, S., Mirault, D., Mechawar, N., Mittelbronn, M. G. A., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02857-8 · Cited by 21
Adverse Outcome Pathway on Inhibition of the mitochondrial complex I of nigro-striatal neurons leading to parkinsonian motor deficits
Bal‐Price, A., Leist, M., Schildknecht, S., Monnet‐Tschudi, F., Paini, A., & Terron, A. (2018) · OECD series on adverse outcome pathways · doi:10.1787/b46c3c00-en · Cited by 22
Chemokine CCL2 prevents opioid-induced inhibition of nociceptive synaptic transmission in spinal cord dorsal horn
Heles, M., Mrózková, P., Šulcová, D., Adámek, P., Spicarova, D., & Paleček, J. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02335-4 · Cited by 18
Protective effects of delayed intraventricular TLR7 agonist administration on cerebral white and gray matter following asphyxia in the preterm fetal sheep
Cho, K. H. T., Wassink, G., Galinsky, R., Xu, B., Mathai, S., Dhillon, S. K., van den Heuij, L. G., Davidson, J. O., Weaver-Mikaere, L., Bennet, L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45872-y · Cited by 18
Microglia activation and inflammation in hippocampus attenuates memory and mood functions during experimentally induced diabetes in rat
Nagayach, A., Bhaskar, R., & Patro, I. K. (2022) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2022.102160 · Cited by 18
Spatial proteomic analysis in human Alzheimer’s disease brains enables identification of microenvironment-dependent microglial cell states
Sanchez-Molina, P., Rosmus, D.-D., Brownell, D., Meral, M., Gohlich, C., Pratapa, A., Peymanfar, Y., Whitley, A., Hou, Y., Nikulina, N., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02267-3 · Cited by 21
TREM2 and CD163 Ameliorate Microglia-Mediated Inflammatory Environment in the Aging Brain
Han, X., Liu, Y., Liu, B.-W., Ma, Z., Xia, T., & Gu, X. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-01965-4 · Cited by 17
Aging gene signature of memory CD8+ T cells is associated with neurocognitive functioning in Alzheimer’s disease
Young, J. J., Park, H., Kim, M., Par‐Young, J., Bartlett, H. H., Kim, H. S., Ünlü, S., Osmani, L., Shin, M. S., Bucala, R., et al. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00396-y · Cited by 17
Transcriptomics of Maternal and Fetal Membranes Can Discriminate between Gestational-Age Matched Preterm Neonates with and without Cognitive Impairment Diagnosed at 18–24 Months
Pappas, A., Chaiworapongsa, T., Romero, R. J., Korzeniewski, S. J., Cortez, J. M., Bhatti, G., Gomez‐Lopez, N., Hassan, S. S., Shankaran, S., & Tarca, A. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118573 · Cited by 17
Differential Gene Expression in Sporadic and Genetic Forms of Alzheimer’s Disease and Frontotemporal Dementia in Brain Tissue and Lymphoblastoid Cell Lines
Ramos‐Campoy, O., Lladó, A., Bosch, B., Ferrer, M., Pérez‐Millan, A., Vergara, M., Molina‐Porcel, L., Fort‐Aznar, L., Gonzalo, R., Moreno, F., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02969-2 · Cited by 16
Inflammation and heterogeneity in synucleinopathies
Freuchet, A., Pinçon, A., Sette, A., & Arlehamn, C. S. L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1432342 · Cited by 15
Microglial Phenotyping in Neurodegenerative Disease Brains: Identification of Reactive Microglia with an Antibody to Variant of CD105/Endoglin
Walker, D. G., Lue, L., Beach, T., & Tooyama, I. (2019) · Cells · doi:10.3390/cells8070766 · Cited by 15
CD163-Mediated Small-Vessel Injury in Alzheimer’s Disease: An Exploration from Neuroimaging to Transcriptomics
Chen, Y., Lu, P., Wu, S., Yang, J., Liu, W., Zhang, Z., & Xu, Q. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042293 · Cited by 14
Is There Any Evidence of Monocytes Involvement in Alzheimer’s Disease? A Pilot Study on Human Postmortem Brain
Monoranu, C.-M., Hartmann, T., Strobel, S., Heinsen, H., Riederer, P., Distel, L. V., & Bohnert, S. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210052 · Cited by 14
Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease
Ferreira, S. A., Li, C., Klæstrup, I. H., Vitic, Z., Rasmussen, R. K., Kirkegaard, A., Toft, G. U., Betzer, C., Svendsen, P., Jensen, P. H., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00606-w · Cited by 12
Autophagy Regulation Attenuates Neuroinflammation and Cognitive Decline in an Alzheimer's Disease Mouse Model with Chronic Cerebral Hypoperfusion
Yang, Q., Yang, C., Lv, H., Zheng, X., Mao, S., Liu, N., Mo, S., Liao, B., Yang, M., Lü, Z., et al. (2024) · Inflammation · doi:10.1007/s10753-024-02043-0 · Cited by 12
Activated microglia in acute encephalopathy with biphasic seizures and late reduced diffusion
Fujita, Y., Takanashi, J., Takei, H., Ota, S., Fujii, K., Sakuma, H., & Hayashi, M. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.04.050 · Cited by 11
Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in Alzheimer’s diseasePreprint
Vastrad, B. M., & Vastrad, C. M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.06.442918 · Cited by 11
RNA- and ATAC-sequencing Reveals a Unique CD83+ Microglial Population Focally Depleted in Parkinson’s DiseasePreprint
Chatila, Z. K., Yadav, A., Mares, J., Flowers, X. E., Yun, T., Rashid, M., Talcoff, R., Pelly, Z., Zhang, Y., Jager, P. L. D., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.17.540842 · Cited by 11
Increased Parenchymal Macrophages are associated with decreased Tyrosine Hydroxylase mRNA levels in the Substantia Nigra of people with Schizophrenia and Bipolar Disorder
Victoriano, G. M., Zhu, Y., Middleton, F. A., Massa, P. T., Ajulu, K., Webster, M. J., & Weickert, C. S. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116141 · Cited by 11
Development and validation of a 13-gene signature associated with immune function for the detection of Alzheimer's disease
Zhu, M., Hou, T., Jia, L., Tan, Q., Qiu, C., & Du, Y. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.12.014 · Cited by 10
Indoleamine 2,3-dioxygenase (IDO1) – Can dendritic cells and monocytes expressing this moonlight enzyme change the phase of Parkinson’s Disease?
Gonçalves, M., Rodrigues‐Santos, P., Januário, C., Cosentino, M., & Pereira, F. C. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112062 · Cited by 9
Single-cell transcriptomics for immune profiling of cerebrospinal fluid in neurological diseases
Ramos-Vicente, D., Monterosso, P., de Fàbregues, O., Roch, G., Vila, M., & Bové, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1599303 · Cited by 8
Nucleosome assembly protein 1-like 5 alleviates Alzheimer’s disease-like pathological characteristics in a cell model
Wang, B. J., Liu, W., & Sun, F.-X. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1034766 · Cited by 8
Progranulin deficiency-induced lysosomal dysfunction drives maladaptive myeloid cell states through the MITF/TFE transcription factors
Tejwani, L., Heffner, C. M., Balak, C. D., Skuja, L. L., Tatarakis, D., Rana, A., Yu, S. B., Fitzgerald, G. A., Ha, C., de Melo, G. L., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.07.009 · Cited by 8
Novel insights into molecular signatures and pathogenic cell populations shared by systemic lupus erythematosus and vascular dementia
Chen, J. W., Zhao, X., Huang, C. B., & Lin, J. (2023) · Functional & Integrative Genomics · doi:10.1007/s10142-023-01270-2 · Cited by 7
TAMing Gliomas: Unraveling the Roles of Iba1 and CD163 in Glioblastoma
Fuse, H., Zheng, Y., Alzoubi, I., & Graeber, M. B. (2025) · Cancers · doi:10.3390/cancers17091457 · Cited by 6
Investigating the Relationship of Serum CD163, YKL40 and VILIP-1 Levels with Autism Severity and Language-cognitive Development in Preschool Children with Autism
Demirci, S. C., Barun, S., Özaslan, A., Gülbahar, Ö., Bulut, T. S. D., Çamurdan, A. D., & İşeri, E. (2024) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.23.1149 · Cited by 5
Implications of fractalkine on glial function, ablation and glial proteins/receptors/markers—understanding its therapeutic usefulness in neurological settings: a narrative review
Paul, D., & Basavan, D. (2022) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-022-00446-0 · Cited by 5
A multimodal intervention for Alzheimer’s disease results in multifaceted systemic effects reflected in blood and ameliorates functional and cognitive outcomesPreprint
Roach, J. C., Edens, L., Markewych, D. R., Rapozo, M. K., Hara, J., Glusman, G., Funk, C. C., Bramen, J. E., Baloni, P., Shankle, W. R., et al. (2022) · medRxiv · doi:10.1101/2022.09.27.22280385 · Cited by 5
Rat Microglia Isolation and Characterization Using Multiparametric Panel for Flow Cytometric Analysis
Furman, N. E. T., Prabhakara, K. S., Bedi, S. S., Cox, C. S., & Olson, S. D. (2018) · Neuromethods · doi:10.1007/978-1-4939-8564-7_12 · Cited by 4
The Crosstalk Between Sepsis-Associated Encephalopathy and Alzheimer’s Disease: Identifying Potential Biomarkers and Therapeutic Targets for Cognition
Wang, Z., Zhang, Z., Shi, J., & Zhao, R. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05192-x · Cited by 3
Intracranial inflammation and meningeal fibrosis are associated with perivascular changes, altered CSF tracer dynamics, and cognitive decline in a rat model of communicating hydrocephalus
Wang, C.-L., Tseng, G., Tsai, S., & Chen, L.-J. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-026-00787-5 · Cited by 3
Monocytes in the Characterization of Pain in Palliative Patients with Severe Dementia—A Pilot Study
Ribeiro, H. C., Alves, R., Jorge, J., Gonçalves, A. C., Sarmento‐Ribeiro, A. B., Veríssimo, M. T., Andrade, J. P., & Dourado, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310723 · Cited by 3
MIA and CD163 as promising diagnostic biomarkers in vascular dementia: A multi-method study combining WGCNA, machine learning with validation in animal models and clinical samples
Chen, Y., Chang, Z., Liang, X. M., Miao, L., Chi, X., Liu, H., Shen, W., & Zhang, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115146 · Cited by 2
The volatile oil of Acorus tatarinowii schott significantly attenuates neuroinflammatory damage in a rat model of tourette syndrome by inhibiting the p38 MAPK/NLRP3/STAT3 signaling pathway
Wei, X., Sun, K., Feng, P., Huang, S., Jiang, B., Cui, M., Chen, Y., Xue, F., He, Y., Yao, J., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1540092 · Cited by 2

Authors: Pey, P., Pearce, R. K., Kalaitzakis, M. E., Griffin, W. S. T., & Gentleman, S. M.
Affiliations: Imperial College London (GB)
University of Arkansas for Medical Sciences (US)
Corresponding author: Pey, Peixuan
Gentleman, Steve M
ORCID: Griffin, W Sue T
Gentleman, Steve M
Venue: Acta Neuropathologica Communications
Publisher: Springer Science and Business Media LLC
Published: 2014-02-14
Volume: 2
Issue: 1
Pages: 21-21
ISSN: 2051-5960 (ISSN-L)
DOI: 10.1186/2051-5960-2-21
PMC: PMC3940003
OpenAlex: W2147311470
Cited by: 128
References: 71
Citations by year: 2026: 7 · 2025: 12 · 2024: 10 · 2023: 18 · 2022: 14 · 2021: 11 · 2020: 16 · 2019: 11 · 2018: 8 · 2017: 9 · 2016: 7 · 2015: 5
FWCI: 3.64
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
www.springer.com/tdm (unspecified)
Locations: Acta Neuropathologica Communications (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: Parkinson's UK (G0909, J-1402)
Imperial College London
National Institutes of Health (AG12411)
National Institute on Aging (AG 12411, P01AG012411)
Topics: Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords: CD163, Alzheimer's disease, Parkinson's disease, amyloid plaques, Lewy bodies, CD68, blood-brain barrier, perivascular macrophages, phagocytosis, neuroinflammation
MeSH terms: CD68 Molecule, CD163 Antigen, Aged, Aged, 80 and over, Alzheimer Disease, Brain, Calcium-Binding Proteins, Cell Count, DNA-Binding Proteins, Female, Fibrinogen, Humans, Macrophages, Male, Membrane Glycoproteins, Microfilament Proteins, Middle Aged, Neurologic Examination, Parkinson Disease, Receptors, Cell Surface, Receptors, Immunologic, Antigens, Differentiation, Myelomonocytic, Antigens, CD, Amyloid beta-Peptides, Microglia, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Phenotypic profile of alternative activation marker CD163 is different in Alzheimer’s and Parkinson’s disease

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks